TY  - JOUR
AU  - Radovanović, Marina
AU  - Kekić, Dusan
AU  - Gajić, Ina
AU  - Kabić, Jovana
AU  - Jovićević, Miloš
AU  - Kekić, Natalija
AU  - Opavski, Nataša
AU  - Ranin, Lazar
PY  - 2023
UR  - https://www.frontiersin.org/articles/10.3389/fnut.2023.1054555/full
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC9928729
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5486
AB  - Antimicrobial resistance (AMR) poses a substantial threat to human health. The commensal bacteria of the gut microbiome were shown to serve as a reservoir of antibiotic resistance genes (ARGs), termed the gut resistome, which has the potential to transfer horizontally to pathogens and contribute to the emergence of drug-resistant bacteria. Namely, AMR traits are generally linked with mobile genetic elements (MGEs), which apart from disseminating vertically to the progeny, may cross horizontally to the distantly related microbial species. On the other hand, while probiotics are generally considered beneficiary to human health, and are therefore widely consumed in recent years most commonly in conjunction with antibiotics, the complexities and extent of their impact on the gut microbiome and resistome have not been elucidated. By reviewing the latest studies on ARG containing commercial probiotic products and common probiotic supplement species with their actual effects on the human gut resistome, this study aims to demonstrate that their contribution to the spread of ARGs along the GI tract merits additional attention, but also indicates the changes in sampling and profiling of the gut microbiome which may allow for the more comprehensive studying of the effects of probiotics in this part of the resistome.
PB  - Frontiers Media S.A.
T2  - Frontiers in Nutrition
T1  - Potential influence of antimicrobial resistance gene content in probiotic bacteria on the gut resistome ecosystems
VL  - 10
DO  - 10.3389/fnut.2023.1054555
SP  - 1054555
ER  - 

@article{
author = "Radovanović, Marina and Kekić, Dusan and Gajić, Ina and Kabić, Jovana and Jovićević, Miloš and Kekić, Natalija and Opavski, Nataša and Ranin, Lazar",
year = "2023",
abstract = "Antimicrobial resistance (AMR) poses a substantial threat to human health. The commensal bacteria of the gut microbiome were shown to serve as a reservoir of antibiotic resistance genes (ARGs), termed the gut resistome, which has the potential to transfer horizontally to pathogens and contribute to the emergence of drug-resistant bacteria. Namely, AMR traits are generally linked with mobile genetic elements (MGEs), which apart from disseminating vertically to the progeny, may cross horizontally to the distantly related microbial species. On the other hand, while probiotics are generally considered beneficiary to human health, and are therefore widely consumed in recent years most commonly in conjunction with antibiotics, the complexities and extent of their impact on the gut microbiome and resistome have not been elucidated. By reviewing the latest studies on ARG containing commercial probiotic products and common probiotic supplement species with their actual effects on the human gut resistome, this study aims to demonstrate that their contribution to the spread of ARGs along the GI tract merits additional attention, but also indicates the changes in sampling and profiling of the gut microbiome which may allow for the more comprehensive studying of the effects of probiotics in this part of the resistome.",
publisher = "Frontiers Media S.A.",
journal = "Frontiers in Nutrition",
title = "Potential influence of antimicrobial resistance gene content in probiotic bacteria on the gut resistome ecosystems",
volume = "10",
doi = "10.3389/fnut.2023.1054555",
pages = "1054555"
}

Radovanović, M., Kekić, D., Gajić, I., Kabić, J., Jovićević, M., Kekić, N., Opavski, N.,& Ranin, L.. (2023). Potential influence of antimicrobial resistance gene content in probiotic bacteria on the gut resistome ecosystems. in Frontiers in Nutrition
Frontiers Media S.A.., 10, 1054555.
https://doi.org/10.3389/fnut.2023.1054555

Radovanović M, Kekić D, Gajić I, Kabić J, Jovićević M, Kekić N, Opavski N, Ranin L. Potential influence of antimicrobial resistance gene content in probiotic bacteria on the gut resistome ecosystems. in Frontiers in Nutrition. 2023;10:1054555.
doi:10.3389/fnut.2023.1054555 .

Radovanović, Marina, Kekić, Dusan, Gajić, Ina, Kabić, Jovana, Jovićević, Miloš, Kekić, Natalija, Opavski, Nataša, Ranin, Lazar, "Potential influence of antimicrobial resistance gene content in probiotic bacteria on the gut resistome ecosystems" in Frontiers in Nutrition, 10 (2023):1054555,
https://doi.org/10.3389/fnut.2023.1054555 . .

TY  - JOUR
AU  - Radovanović, Marina
AU  - Kekić, Dušan
AU  - Jovičević, Miloš
AU  - Kabić, Jovana
AU  - Gajić, Ina
AU  - Opavski, Nataša
AU  - Ranin, Lazar
PY  - 2022
UR  - http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC9697523
UR  - https://www.mdpi.com/2076-0817/11/11/1230
UR  - http://radar.ibiss.bg.ac.rs/handle/123456789/5240
AB  - Neisseria gonorrhoeae (N. gonorrhoeae) is the etiological agent of the second most common sexually transmitted disease in the world, gonorrhoea. Currently recommended and last available first-line therapy is extended-spectrum cephalosporins most often combined with azitromycin. However, misuse of antibiotics and the abilities of N. gonorrhoeae to acquire new genetic and plasmid-borne resistance determinants has gradually led to the situation where this bacterium has become resistant to all major classes of antibiotics. Together with a generally slow update of treatment guidelines globally, as well as with the high capacity of gonococci to develop and retain AMR, this may lead to the global worsening of gonococcal AMR. Since effective vaccines are unavailable, the management of gonorrhoea relies mostly on prevention and accurate diagnosis, together with antimicrobial treatment. The study overviews the latest results of mostly WHO-initiated studies, primarily focusing on the data regarding the molecular basis of the resistance to the current and novel most promising antibacterial agents, which could serve to establish or reinforce the continual, quality-assured and comparable AMR surveillance, including systematic monitoring and treatment with the use of molecular AMR prediction methods.
PB  - Basel: MDPI
T2  - Pathogens
T1  - Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions
IS  - 11
VL  - 11
DO  - 10.3390/pathogens11111230
SP  - 1230
ER  - 

@article{
author = "Radovanović, Marina and Kekić, Dušan and Jovičević, Miloš and Kabić, Jovana and Gajić, Ina and Opavski, Nataša and Ranin, Lazar",
year = "2022",
abstract = "Neisseria gonorrhoeae (N. gonorrhoeae) is the etiological agent of the second most common sexually transmitted disease in the world, gonorrhoea. Currently recommended and last available first-line therapy is extended-spectrum cephalosporins most often combined with azitromycin. However, misuse of antibiotics and the abilities of N. gonorrhoeae to acquire new genetic and plasmid-borne resistance determinants has gradually led to the situation where this bacterium has become resistant to all major classes of antibiotics. Together with a generally slow update of treatment guidelines globally, as well as with the high capacity of gonococci to develop and retain AMR, this may lead to the global worsening of gonococcal AMR. Since effective vaccines are unavailable, the management of gonorrhoea relies mostly on prevention and accurate diagnosis, together with antimicrobial treatment. The study overviews the latest results of mostly WHO-initiated studies, primarily focusing on the data regarding the molecular basis of the resistance to the current and novel most promising antibacterial agents, which could serve to establish or reinforce the continual, quality-assured and comparable AMR surveillance, including systematic monitoring and treatment with the use of molecular AMR prediction methods.",
publisher = "Basel: MDPI",
journal = "Pathogens",
title = "Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions",
number = "11",
volume = "11",
doi = "10.3390/pathogens11111230",
pages = "1230"
}

Radovanović, M., Kekić, D., Jovičević, M., Kabić, J., Gajić, I., Opavski, N.,& Ranin, L.. (2022). Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions. in Pathogens
Basel: MDPI., 11(11), 1230.
https://doi.org/10.3390/pathogens11111230

Radovanović M, Kekić D, Jovičević M, Kabić J, Gajić I, Opavski N, Ranin L. Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions. in Pathogens. 2022;11(11):1230.
doi:10.3390/pathogens11111230 .

Radovanović, Marina, Kekić, Dušan, Jovičević, Miloš, Kabić, Jovana, Gajić, Ina, Opavski, Nataša, Ranin, Lazar, "Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions" in Pathogens, 11, no. 11 (2022):1230,
https://doi.org/10.3390/pathogens11111230 . .